Several recent surveys indicate that pharmaceutical companies will spend more money on email marketing to consumers in 2005 (see "DTC in 2005: Can You Teach Old Dogs New Tricks?
"). Perhaps they should also spend some money and time to ensure that their email campaigns adhere to emerging best practices with regard to privacy, HIPAA, SPAM, and permission-based marketing.
Topics discussed include::
- Security Breaches
- Federal and state laws that impact email to consumers
- Vendor Critical Self-Assessment
- Simple Rules to Remember